Short NRSN - IPO Lockup Expires 6/7/2022Little to no news, increasing net revenue losses year-over-year and tremendously spike in short-interest, now would be a good time to short. Between the earnings call and expiring IPO lockup, NRSN leaning towards a dramatic drop. Shortby ThomasTuanNguyen2
NRSN Remember that low liquidity IPO?For those of you who haven`t bought the NRSN IPO, the chart went exactly like this: after NeuroSense Therapeutics Received FDA Clearance of IND for PrimeC for the Treatment of ALS today!Longby TopgOptions339
NRSN High Volatility IPONeuroSense Therapeutics Ltd. (NRSN) listed yesterday only 2,000,000 shares on NASDAQ Capital at a price of $6.00. Due to the extremely low liquidity, high volatility is expected. I rarely see 2Mil shares float in a stock which also dropped from 6usd to 3.83usd in the pre-market right now. I rate this a Buy!Longby TopgOptions666